Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
An Open-Label, Multicenter, Multi-arm Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1805 in Adults With Advanced Solid Tumors
Sponsor: Sairopa B.V.
This PHASE1 trial investigates CRC, Colorectal Cancer and Endometrial Cancer and is currently actively recruiting participants. Sairopa B.V. leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE1
-
Sep 2025 — Jan 2026 [monthly]
Recruiting PHASE1
-
Jun 2025 — Sep 2025 [monthly]
Recruiting PHASE1
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
▶ Show 1 earlier version
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE1
First recorded
Apr 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sairopa B.V.
For direct contact, visit the study record on ClinicalTrials.gov .